BioSpace News Archive

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced that it will be presenting virtually at the upcoming Zooming with LD Micro event on Wednesday, October 14 at 11 a.m. ET.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for AB201 (rNAPc2) as a potential treatment for patients hospitalized with COVID-19.

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) to increase the maximum allowable dose of 60 mg with Palynziq® (pegvaliase-pqpz) Injection for treatment of adults with Phenylketonuria (PKU).

LION Eye Group, a network of independent optometry practices that utilizes various key initiatives and protocols across strategic and non-clinical operational disciplines to increase provider profitability, entered into a Vendor Agreement with WestGroupe Optical, Inc.

NuGenerex Immuno-Oncology (NGIO), a subsidiary of Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce the closing of a Licensing & Distribution Agreement with Bintai Kinden Corporation of Malaysia for the development and commercialization of the Ii-Key-SARS-CoV-2 coronavirus vaccine

Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits introduces the new Swift 2S Sonic DNA Library Kit to the NGS Industry. After a tremendously successful debut of Swift 2S Turbo ‘s low-cost enzymatic fra

Enterprise’s novel TMEM16A potentiator portfolio includes ETD002, a first in class compound which is currently in Phase 1

On 22 October, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the third quarter 2020.

The global urology devices market is driven by high prevalence and rapid increase in incidence of urology disorder associated with the urinary tract system across the globe.

A transfusion technology device is an electromechanical device that ensures the safety of a patient during blood transfusion and donation.